HUNTSMAN RONALD KIRK enters VIVOS THERAPEUTICS, INC. with 1.75M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 12/10/2020ACC: 0001493152-20-023328
DirectorOfficer10% Owner· Chairman & CEO
Since Dec 2020
1.75M
Baseline shares
0.00
Direct ownership
0 positions
333.33K
Derivative underlying
1 instrument
1
Security positions
1.75M indirect
Non-Derivative Holdings1
Common Stock
IndirectShares owned1.75M
Total
1.75M indirect1.75M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.75M | Indirect |
| Total | 1.75M | 1.75M indirect |
Derivative Holdings1
Stock option
DirectUnderlying security
Common Stock
Underlying shares
333.33K
Shares owned
N/A
Exercise price
1.65
Expiration
—
Exercise window
—
Total
Underlying
333.33K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock option Direct | Common Stock | 1.65 | — | — | 333.33K | N/A |
| Total | 333.33K | 0.00 | ||||